DK0408284T3 - Amylin til behandling af knoglelidelser - Google Patents

Amylin til behandling af knoglelidelser

Info

Publication number
DK0408284T3
DK0408284T3 DK90307471.4T DK90307471T DK0408284T3 DK 0408284 T3 DK0408284 T3 DK 0408284T3 DK 90307471 T DK90307471 T DK 90307471T DK 0408284 T3 DK0408284 T3 DK 0408284T3
Authority
DK
Denmark
Prior art keywords
amylin
bone
treatment
disorders
variants
Prior art date
Application number
DK90307471.4T
Other languages
Danish (da)
English (en)
Inventor
Iain Macintyre
Original Assignee
Amylin Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amylin Pharmaceuticals Inc filed Critical Amylin Pharmaceuticals Inc
Application granted granted Critical
Publication of DK0408284T3 publication Critical patent/DK0408284T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/225—Calcitonin gene related peptide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
DK90307471.4T 1989-07-08 1990-07-09 Amylin til behandling af knoglelidelser DK0408284T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898915712A GB8915712D0 (en) 1989-07-08 1989-07-08 Medical treatment

Publications (1)

Publication Number Publication Date
DK0408284T3 true DK0408284T3 (da) 1996-06-03

Family

ID=10659773

Family Applications (2)

Application Number Title Priority Date Filing Date
DK90307471.4T DK0408284T3 (da) 1989-07-08 1990-07-09 Amylin til behandling af knoglelidelser
DK040191A DK40191A (da) 1989-07-08 1991-03-07 Behandling af knoglelidelser

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK040191A DK40191A (da) 1989-07-08 1991-03-07 Behandling af knoglelidelser

Country Status (12)

Country Link
EP (1) EP0408284B1 (es)
JP (1) JPH04500691A (es)
AT (1) ATE137975T1 (es)
CA (1) CA2020752C (es)
DE (1) DE69026986T2 (es)
DK (2) DK0408284T3 (es)
ES (1) ES2088971T3 (es)
GB (1) GB8915712D0 (es)
GR (1) GR3020680T3 (es)
IE (1) IE62625B1 (es)
SG (1) SG46382A1 (es)
WO (1) WO1991000710A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2109794A1 (en) * 1991-05-24 1992-11-26 Timothy J. Rink Amylin and possibly insulin containing composition for the treatment of anorexia and related states
AU2169392A (en) * 1991-05-24 1992-12-30 Amylin Pharmaceuticals, Inc. Insulin and amylin containing composition for the treatment of insulin deficient mammals
US5688938A (en) * 1991-08-23 1997-11-18 The Brigham & Women's Hospital, Inc. Calcium receptor-active molecules
US6313146B1 (en) 1991-08-23 2001-11-06 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6001884A (en) * 1991-08-23 1999-12-14 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6031003A (en) * 1991-08-23 2000-02-29 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5858684A (en) * 1991-08-23 1999-01-12 The Brigham And Women's Hospital, Inc. Method of screening calcium receptor-active molecules
US5763569A (en) * 1991-08-23 1998-06-09 The Brigham And Women's Hospital, Inc Calcium receptor-active molecules
US6011068A (en) * 1991-08-23 2000-01-04 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
WO1993019774A1 (en) * 1992-04-03 1993-10-14 Amylin Pharmaceuticals, Inc. Amylin and possibly insulin containing composition for the treatment of anorexia and related states
US5962314A (en) * 1993-02-23 1999-10-05 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
DK1203761T3 (da) 1994-12-08 2005-04-11 Nps Pharma Inc Calciumreceptoraktive forbindelser
JP4117506B2 (ja) 1996-05-01 2008-07-16 エヌピーエス ファーマシューティカルズ インコーポレイテッド 無機イオン活性化合物
WO1999016406A2 (en) * 1997-09-26 1999-04-08 Auckland Uniservices Limited Therapeutic method

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4925833A (en) * 1983-12-29 1990-05-15 The Research Foundation Of State University Of New York Use of tetracycline to enhance bone protein synthesis and/or treatment of osteoporosis
GB8407907D0 (en) * 1984-03-27 1984-05-02 Sandoz Ltd Organic compounds
US4588716A (en) * 1984-05-04 1986-05-13 Wisconsin Alumni Research Foundation Method for treating metabolic bone disease in mammals
JPS62129297A (ja) * 1985-08-09 1987-06-11 Toyo Jozo Co Ltd カルシトニン遺伝子関連ペプチド誘導体
US4677132A (en) * 1986-03-12 1987-06-30 American Home Products Corporation Inhibition of bone resorption by etodolac
GB8720115D0 (en) * 1987-08-26 1987-09-30 Cooper G J S Treatment of diabetes mellitus
HU203198B (en) * 1987-10-26 1991-06-28 Sandoz Ag Process for producing pharmaceutical compositions having immunity-inhibiting, monokin-, particularly interleukin-1-inhibiting effect
DE68918449T2 (de) * 1988-07-22 1995-05-11 Ethyl Corp Siliziumverbindungen zur behandlung von knochen.

Also Published As

Publication number Publication date
EP0408284A2 (en) 1991-01-16
DE69026986D1 (de) 1996-06-20
ES2088971T3 (es) 1996-10-01
EP0408284B1 (en) 1996-05-15
GB8915712D0 (en) 1989-08-31
DK40191D0 (da) 1991-03-07
SG46382A1 (en) 1998-02-20
GR3020680T3 (en) 1996-10-31
JPH04500691A (ja) 1992-02-06
IE902494A1 (en) 1991-02-13
ATE137975T1 (de) 1996-06-15
DK40191A (da) 1991-03-07
CA2020752A1 (en) 1992-01-10
DE69026986T2 (de) 1996-10-02
WO1991000710A1 (en) 1991-01-24
IE62625B1 (en) 1995-02-22
EP0408284A3 (en) 1992-01-08
CA2020752C (en) 1996-12-24

Similar Documents

Publication Publication Date Title
DK0408284T3 (da) Amylin til behandling af knoglelidelser
ITFI910071U1 (it) Piastra per osso per la porzione distale dell'omero.
ATE111331T1 (de) Schiene zur behandlung der fraktur von colles.
IS5468A (is) Notkun á estrogeni til framleiðslu á lyfi til meðhöndlunar vegna tíðahvarfa
DE3782749D1 (de) Material fuer orthopaedische/orthotische schienen.
AU1808488A (en) Compounds for the treatment of alzheimer's disease
GB2193102B (en) Fracture brace
IL88080A0 (en) Substituted tetralins,chromans and related compounds in the treatment of asthma,arthritis and related diseases
GB8621816D0 (en) Therapeutic composition
FR2651435B1 (es)
EP0330756A3 (en) Thienotricyclics for the treatment of bronchial diseases
GB8903565D0 (en) Bone cements
EP0295827A3 (en) Use of 24,25-dihydroxy-cholecalciferol in mending bone fractures
EP0486584A4 (en) Dopaminergic neurotrophic factor for treatment of parkinson's disease
NZ221473A (en) Octapeptide somatostatin analogue "octreotide" in nasal compositions
IT8622451A0 (it) Protesi ortopedica per la riduzione di fratture ossee, materiale per la sua fabbricazione e procedimenti per ottenerli.
Chung et al. A New Classification of Polydactyly and It s Application to the Treatment
EP0173527A3 (en) Insulin-selective somatostatin analogs
IT1217837B (it) Procedimento per la preparazione del "alfa /4(1,1 dimetiletil)fenil/piperidinbutanolo"
GB8908549D0 (en) Liquid leather treatment composition
GR860897B (en) Woman's heel
IT1238692B (it) Composizioni farmaceutiche a base di calcitonina per la somministrazione sublinguale
ES2015772A6 (es) Procedimiento e obtencion de nuevos derivados del 5-fluorouracilo, concretamente los n1-acil-sustituidos-n3-orto-toluil-5-fluorouracilo.
IT1238074B (it) Composti per il trattamento della malattia di paget,dell'ipercalcemia e dell'osteoporosi ottenuti per complessazione di una delle calcitonine con una ciclodestrina, loro preparazione e relative composizioni farmaceutiche